Intravenous Dexamethasone for Ropivacaine Axillary Block

• Status: Completed
• Trial end date: 2017-09-16
• Target enrollment: 0
• Participant gender: All

Summary

Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Besancon
• Treatments: Anesthetics; BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Ropivacaine

Criteria

Inclusion Criteria:

• ASA 1,2 et 3

• surgery under axillary brachial plexus block

• aged >18 years

• signed information consent

Exclusion Criteria:

• impaired coagulation

• contraindication to regional anesthesia or technical impossibility

• opioids or pain killers abuse or addiction

• steroids consumption in the past 6 months

• dementia or under administrative supervision

• delay of surgery to short to allow regional anesthesia

• pregnancy and breastfeeding

• allergy and contraindication to dexamethasone or ropivacaine

• anticipated bad observation of treatment

• patient enrolled in another trial